1 / 4

Cilostazol – CILON T

Cilostazol – CILON T. Objective: to report the clinical outcomes of cilostazol in addition to dual antiplatelet therapy at 6 months Study : multicenter randomized trial Population: patients were treated with DES Endpoint : composite death , non-fatal; MI, ischemic stroke, TLR.

dixon
Télécharger la présentation

Cilostazol – CILON T

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cilostazol – CILON T Objective: to report the clinicaloutcomes of cilostazol in addition to dual antiplatelettherapyat 6 monthsStudy: multicenterrandomized trialPopulation: patients weretreatedwith DESEndpoint: composite death, non-fatal; MI, ischemic stroke, TLR

  2. Cilostazol – CILON T

  3. Cilostazol – CILON T

  4. Cilostazol – CILON T Conclusion addition of cilostazol to aspirin and clopidogrelfailed to reduce adverse eventsat 6 months Suk JACC 2011;57:280-9

More Related